Does India need a new pharmaceutical policy? Examining the implications of the drug price control order.

Kumar, Rupali; Joshi, Mahika Milind; Palod, Rajat Jagdish; Dharmagadda, Sreedhar

Kumar, Rupali; Joshi, Mahika Milind; Palod, Rajat Jagdish; Dharmagadda, Sreedhar.

Afiliação

Kumar R; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Joshi MM; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Palod RJ; Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Dharmagadda S; Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka, India.

Int J Health Plann Manage ; 37(6): 3028-3038, 2022 Nov.

Article em En | MEDLINE | ID: mdl-35983617

Assuntos

Custos de Medicamentos; Controle de Medicamentos e Entorpecentes; Medicamentos Genéricos; Custos e Análise de Custo; Seguridade Social

Palavras-chave

DPCO 2013; National pharmaceutical pricing authority; pharmaceutical policy India; price control order

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Custos de Medicamentos / Controle de Medicamentos e Entorpecentes Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Int J Health Plann Manage Assunto da revista: PESQUISA EM SERVICOS DE SAUDE / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google